tiprankstipranks
Intra-Cellular Therapies (ITCI)
NASDAQ:ITCI

Intra-Cellular Therapies (ITCI) Cash flow

804 Followers

Intra-Cellular Therapies Cash Flow

ITCI's free cash flow for Q3 2023 was $-25.54M. For the 2023 fiscal year, ITCI's free cash flow was decreased by $-11.10M and operating cash flow was $-25.27M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -161.33M$ -270.19M$ -259.54M$ -230.07M$ -127.98M$ -118.17M
Investing Cash Flow
$ 108.38M$ -128.37M$ 280.34M$ -480.30M$ 177.44M$ 134.64M
Financing Cash Flow
$ 16.99M$ 455.16M$ 11.52M$ 664.18M$ 3.24M$ 685.19K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 473.00M$ 150.37M$ 93.77M$ 61.45M$ 107.64M$ 54.95M
Income Tax Paid Supplemental Data
$ 6.00K$ 6.00K$ 6.00K$ 1.60K$ 1.60K$ 1.60K
Interest Paid Supplemental Data
-----$ 0.00
Issuance Of Capital Stock
$ -7.00K$ 433.72M-$ 652.71M$ 0.00$ 0.00
Issuance Of Debt
-----$ 0.00
Repayment Of Debt
-----$ 0.00
Free Cash Flow
$ -161.57M$ -270.96M$ -259.87M$ -230.34M$ -128.68M$ -118.56M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Intra-Cellular Therapies Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis